![史上最大“三巫日”撞上指数调整 美股还能“波澜不惊”吗?](https://i-invdn-com.investing.com/news/external-images-thumbnails/picc30faa88c71e849d827085aac2377c81.png)
注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Citius Pharmaceuticals Inc是一家制药公司。该公司开发和商业化重症监护产品,重点是辅助癌症治疗、处方产品和干细胞治疗中的抗感染药物。其产品包括Mino-Lok、Mino-Wrap、Halo-Lido、NoveCite和I/ONTAK。I/ONTAK是一种工程化的IL-2白喉毒素融合蛋白,用于治疗持续性或复发性皮肤T细胞淋巴瘤患者。其Mino-Lok是一种抗生素封管液,用于通过抢救受感染的导管来治疗导管相关血流感染患者。其Halo-Lido是一种皮质类固醇-利多卡因外用制剂,旨在为痔疮患者提供抗炎和麻醉缓解。该公司的Mino-Wrap是一种基于液化凝胶的包裹物,用于减少乳房重建手术后的组织扩张器感染。其NoveCite是一种间充质干细胞疗法,用于治疗急性呼吸系统疾病综合征(ARDS)。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Suren G. Dutia | 81 | 2015 | Independent Director |
Leonard L. Mazur | 79 | 2014 | Co-Founder, CEO, Chairman & Secretary |
Carol A. Webb | 77 | 2016 | Independent Director |
Myron Z. Holubiak | 77 | 2015 | Co-Founder & Executive Vice Chairman |
Mark Rupp | - | - | Member of Scientific Advisory Board |
Leonard A. Mermel | - | 2018 | Member of Scientific Advisory Board |
Issam Raad | - | - | Chairman of Scientific Advisory Board |
Perenlei Enkhbaatar | - | - | ARDS Scientific Advisory Board Member |
Eugene Holuka | 65 | 2016 | Independent Director |
John G. Laffey | - | 2021 | ARDS Scientific Advisory Board Member |
Mitchell M. Levy | - | - | ARDS Scientific Advisory Board Member |
Dennis M. McGrath | 67 | 2023 | Independent Director |
Lorraine B. Ware | - | - | ARDS Scientific Advisory Board Member |
Michael A. Matthay | - | - | ARDS Scientific Advisory Board Member |
Joel Rosenblatt | - | - | Member of Scientific Advisory Board |
Robert J. Smith | 63 | 2024 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核